Showing results (1-10 of 115) with videos related to
Sort By:
Pageof 12
Expert Opinion on Biological Therapy|April 28, 2010
Rituximab in hematopoietic cell transplantationSally Arai, David B MiklosHematology/Oncology Clinics of North America|June 22, 2023
Chimeric Antigen Receptor T-Cell Therapy in Aggressive B-Cell LymphomaMark P Hamilton, David B MiklosCancer Discovery|December 7, 2017
CNS Endothelial Cell Activation Emerges as a Driver of CAR T Cell-Associated NeurotoxicityCrystal L Mackall, David B MiklosInternational Journal of Hematology|March 28, 2015
Therapeutic benefits targeting B-cells in chronic graft-versus-host diseaseHideki Nakasone, Bita Sahaf, David B MiklosMethods in Molecular Biology (Clifton, N.J.)|March 4, 2011
Recombinant antigen microarrays for serum/plasma antibody detectionPersis P Wadia, Bita Sahaf, David B MiklosTransplantation and Cellular Therapy|August 8, 2022
Perspective: An International Fludarabine Shortage: Supply Chain Issues Impacting Transplantation and Immune Effector Cell Therapy DeliveryRichard T Maziarz, Amber Diaz, David B Miklos, et al.Immunologic Research|May 1, 2014
Clinical impact of H-Y alloimmunityRakesh Popli, Bita Sahaf, Hideki Nakasone, et al.Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 29, 2008
Renal pathology in hematopoietic cell transplantation recipientsMegan L Troxell, Maricel Pilapil, David B Miklos, et al.Targeted Oncology|March 4, 2025
Leveraging the Immunomodulatory Potential of Ibrutinib for Improved Outcomes of T Cell-Mediated Therapies of B Cell Malignancies: A Narrative ReviewDavid B Miklos, Peter A Riedell, Alex Bokun, et al.Proceedings of the National Academy of Sciences of the United States of America|February 6, 2013
H-Y antigen-binding B cells develop in male recipients of female hematopoietic cells and associate with chronic graft vs. host diseaseBita Sahaf, Yang Yang, Sally Arai, et al.Pageof 12